xanthine has been researched along with Syndrome in 1 studies
7H-xanthine : An oxopurine in which the purine ring is substituted by oxo groups at positions 2 and 6 and N-7 is protonated.
9H-xanthine : An oxopurine in which the purine ring is substituted by oxo groups at positions 2 and 6 and N-9 is protonated.
Syndrome: A characteristic symptom complex.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Thomassen, A | 1 |
Nielsen, TT | 1 |
Bagger, JP | 1 |
Pedersen, AK | 1 |
Henningsen, P | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Phase III Study of Intravenous Glutamate Infusion for Metabolic Protection of the Heart in Surgery for Unstable Coronary Artery Disease[NCT00489827] | Phase 3 | 865 participants (Actual) | Interventional | 2005-10-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Number of patients with atrial fibrillation recorded postoperatively (NCT00489827)
Timeframe: Hospital stay
Intervention | Participants (Count of Participants) |
---|---|
Intravenous Glutamate | 147 |
Saline Infusion | 152 |
ICU duration of stay (hours) (NCT00489827)
Timeframe: ICU stay
Intervention | hours (Median) |
---|---|
Intravenous Glutamate | 21 |
Saline Infusion | 21 |
(NCT00489827)
Timeframe: 30 days
Intervention | Participants (Count of Participants) |
---|---|
Intravenous Glutamate | 31 |
Saline Infusion | 25 |
Incidence of Postoperative stroke < 24 hours of surgery verifed by CT-scan (NCT00489827)
Timeframe: 24 hours
Intervention | Participants (Count of Participants) |
---|---|
Intravenous Glutamate | 4 |
Saline Infusion | 6 |
Hemodynamic instability despite inotropes or need for IABP at the end of surgery in patients with severely reduced left ventricular ejection fraction (LVEF<0.40) (NCT00489827)
Timeframe: End of surgery
Intervention | Participants (Count of Participants) |
---|---|
Intravenous Glutamate | 1 |
Saline Infusion | 5 |
maximum p-creatinine value recorded postoperatively < 30 days (NCT00489827)
Timeframe: 30 days
Intervention | µmol/L (Mean) |
---|---|
Intravenous Glutamate | 106 |
Saline Infusion | 106 |
Severe circulatory failure according to prespecified criteria as judged by a blinded endpoints committee in CCS class IV patients (NCT00489827)
Timeframe: 30 days
Intervention | Participants (Count of Participants) |
---|---|
Intravenous Glutamate | 3 |
Saline Infusion | 16 |
p-CK-MB postoperative day 1, p-troponin-T postoperative day 3 (NCT00489827)
Timeframe: perioperative
Intervention | µg/L (Median) | |
---|---|---|
CK-MB day 1 | Troponin-T day 3 | |
Intravenous Glutamate | 14 | 0.27 |
Saline Infusion | 14 | 0.24 |
Mixed venous oxygen saturation (SvO2) measured at weaning from cardiopulmonary bypass and on arrival to ICU (NCT00489827)
Timeframe: Until arrival to ICU
Intervention | percentage of saturated hemoglobin (Mean) | |
---|---|---|
SvO2 at weaning from CPB | SvO2 on arrival to ICU | |
Intravenous Glutamate | 72.0 | 65.0 |
Saline Infusion | 72.2 | 64.9 |
1 other study available for xanthine and Syndrome
Article | Year |
---|---|
Antiischemic and metabolic effects of glutamate during pacing in patients with stable angina pectoris secondary to either coronary artery disease or syndrome X.
Topics: Adult; Angina Pectoris; Cardiac Pacing, Artificial; Coronary Angiography; Coronary Disease; Electroc | 1991 |